Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Placenta Accreta Spectrum

Interventions

DRUG

oxytocin

Uterotonics will be given in the form of an IV bolus of 10 units of oxytocin immediately with the uterine incision

OTHER

placebo

IV bolus of normal saline immediately with the uterine incision

Trial Locations (1)

RECRUITING

Cairo University, Cairo

All Listed Sponsors

lead

Cairo University

OTHER